Delivery Order SPE2DB20D3505-SPE2DB23FT2F7
Award Date 10/11/22
Potential Completion Date 10/12/22
Potential Value $2.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,199.30 firm fixed-price delivery order is for the supply of 4 mg ondansetron hydrochloride tablets. The contract has an ultimate completion date of May 4, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award, valued at $33,831.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4,566,518,728 tablets of Ondansetron HCL 4 mg, a medication used to treat nausea and vomiting. The contract has a Firm Fixed Price pricing type and a completion date of November 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $14,428.49 firm-fixed-price delivery order is for 4,562,354,992 units of the drug Ondansetron HCL 4 mg Tablet, with a completion date of October 2, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award, valued at $4,879.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,723,201 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. This is a firm-fixed-price delivery order contract with a completion date of November 7, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite...
- This federal contract award, valued at $31,092.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,675,706 Ondansetron HCL 4 mg tablets in lots of 500 each. This delivery order contract has a firm fixed price and an ultimate completion date of May 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,684.77 firm fixed-price delivery order contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of August 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $28,045.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4 mg Ondansetron hydrochloride tablets, a medication used to prevent nausea and vomiting. The contract has a firm-fixed price pricing type and a completion date of February 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,554.56 firm-fixed-price delivery order is for the supply of 4 mg ondansetron hydrochloride tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of March 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $10,824.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a completion date of February 13, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,994.86, is for the delivery of 4,566,523,540 units of Ondansetron HCL 4 MG tablets. It is a firm fixed-price delivery order contract with a completion date of November 25, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...